TrialThe Lancet. Oncology2017
Dabrafenib plus trametinib in patients with previously untreated BRAF
David Planchard et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
513 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialThe Lancet. Oncology2017
David Planchard et al.PubMed ↗Publisher ↗
No numbers read from the abstract.